Search for: "Endo Pharmaceutical"
Results 21 - 40
of 255
Sorted by Relevance
|
Sort by Date
1 Mar 2024, 12:39 pm
Read More False Claims Act Healthcare & Pharmaceutical Fraud I Think I Have a Whistleblower Case Contact Us Confidentially Read Catch of the Week – Endo Health Solutions at constantinecannon.com [read post]
19 Aug 2018, 9:59 pm
By Donald Zuhn -- Last month, in Endo Pharmaceuticals Solutions, Inc. v. [read post]
28 Sep 2010, 4:09 am
Endo Pharmaceuticals said Tuesday that it would buy the rival American generic drug maker to add to its offer of treatments for pain and in the field of urology. [read post]
16 May 2019, 8:15 am
(collectively, “Actavis”) failed to prove by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals and Mallinckrodt LLC (collectively, “Endo”) were invalid. [read post]
24 Feb 2014, 8:37 am
According to DOJ’s press release: Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. [read post]
16 May 2019, 8:15 am
(collectively, “Actavis”) failed to prove by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals and Mallinckrodt LLC (collectively, “Endo”) were invalid. [read post]
15 Jan 2018, 6:56 am
The San Francisco Business Times reported that if Endo Pharmaceuticals complies with the Food and Drug Administration’s request to remove Opana ER (oxymorphone hydrochloride), “it could be a boon for Impax Laboratories,” who manufactures “a generic form of Opana ER before the drug was reformulated by Endo. [read post]
28 Jul 2008, 4:29 pm
Endo (NASDAQ:ENDP) and Penwest Pharmaceuticals Co., which make and sell Opana ER, sued Impax based on an amendment to that application. [read post]
10 Jun 2019, 10:59 am
Slatery III has filed suit against Endo Pharmaceuticals and Endo Health Solutions Inc. [read post]
28 Aug 2006, 8:51 pm
by David Harper Endo Pharmaceuticals announced today that it has reached an agreement with The Purdue Frederick Company settling a long-standing patent infringement case concerning Endo's generic equivalent to Oxycontin, sold by Purdue. [read post]
24 Oct 2016, 11:00 pm
€ 160 The post USA: Endo Pharmaceuticals Inc. v. [read post]
6 Apr 2014, 10:00 pm
In Endo Pharmaceuticals, Inc. v. [read post]
28 Sep 2010, 9:58 am
Branded drugmaker Endo Pharmaceuticals has agreed to pay $1.2 billion in cash to buy privately held Qualitest Pharmaceuticals, the country's sixth-largest generic drugmaker. [read post]
19 Apr 2018, 12:00 am
Endo acquired Par Pharmaceuticals (“Par”) in 2015. [read post]
18 Apr 2016, 12:49 pm
The complaint also names Allergan plc, the parent company of Watson, and Endo International plc, the parent company of Endo Pharmaceuticals Inc. [read post]
5 Feb 2014, 9:21 am
Endo Pharmaceuticals Inc. v. [read post]
28 Oct 2021, 7:40 am
As the sprawling New York State opioid trial heads into the last week of October, attention has shifted toward a court-commissioned referee report recommending sanctions against the defense law firm Arnold & Porter Kaye Scholer (APKS), which represented Endo Pharmaceuticals in the ongoing case. [read post]
9 Jan 2009, 8:21 pm
By Jason Derry --Endo to Acquire Indevus On January 5, 2009, Endo Pharmaceuticals Holdings Inc. announced that it will buy Indevus Pharmaceuticals Inc. for an initial payment of about $370 million and an additional $267 million, based on certain milestones. [read post]
12 Aug 2019, 6:37 am
In June 2019, Attorney General Becerra settled with Endo Pharmaceuticals, securing an eight-year injunction against further pay-for delay agreements and payment of $760,000. [read post]
28 Mar 2008, 9:53 am
Plaintiff: Endo Pharmaceuticals; Penwest Pharmaceuticals Co. [read post]
